Bacteriophages are often considered the natural enemies of bacteria. For many years, scientists have been exploring them as a potential alternative to antibiotics, especially in the era of rapidly spreading antibiotic resistance. However, a new study, published in 2026 in the journal Nature Communications, showed that bacteriophages can not only replace antibiotics but also work with them in surprisingly effective tandem.

The study focused on a patient with cystic fibrosis who suffered from a chronic lung infection caused by the bacterium Pseudomonas aeruginosa. This microorganism is well known to doctors for its ability to develop resistance to many antibiotics and survive in the human body for years.

When traditional treatment proved ineffective, doctors decided to use an experimental combination therapy: the patient was simultaneously prescribed antibiotics and bacteriophages—viruses that can selectively infect and destroy bacteria.

However, the most interesting thing happened during treatment. Researchers began to study in detail how bacteria behaved under the dual pressure of antibiotics and bacteriophages. It turned out that the bacterial population had split into several groups, each of which had chosen its own survival strategy.

Some bacteria became more resistant to bacteriophages but simultaneously lost some of their protection against antibiotics. Others, conversely, retained their resistance to antibiotics but became more vulnerable to bacteriophages. Essentially, bacteria faced a choice: defend against one enemy or the other.

Scientists have dubbed this phenomenon "ecological compartmentalization." It means that bacteria cannot optimally adapt to all threats simultaneously. As a result, bacteriophages and antibiotics begin to support each other by attacking different groups of bacteria.

This discovery is extremely significant for medicine. Until now, phage therapy has often been viewed as an alternative to antibiotics. However, new research demonstrates that the best results can be achieved by combining the two.

This approach appears particularly promising for the treatment of chronic and antibiotic-resistant infections, which remain one of the biggest challenges in modern medicine. If further clinical studies confirm these findings, doctors will be able to use bacteria's evolutionary mechanisms against themselves.

This study demonstrates another important feature of bacteriophages: they can not only destroy bacteria but also force them to make choices that ultimately benefit humans. And it's quite possible that this strategy will become one of the most effective ways to combat infections in the future.